Estimating the Burden of Skin Diseases Using Patient-Reported Daily Time Trade-Off as a Measure of Disease Impact and Unmet Needs

    January 2024 in “ JEADV Clinical Practice
    Y.M.F. Andersen, Claus Zachariae, Simon Francis Thomsen, Jacob P. Thyssen, Alexander Egeberg
    Image of study
    TLDR Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.
    The study involved 6258 patients with five different skin diseases: Alopecia Areata (AA), Hidradenitis Suppurativa (HS), Atopic Dermatitis (AD), psoriasis, and rosacea. It used a measure called daily Time Trade-Off (dTTO) to assess how much time patients are willing to spend on treatment for freedom from disease. The study found that 33.7% of AA patients and 29.3% of HS patients were willing to spend 2 hours or more per day on treatment, indicating a high disease burden and unmet treatment needs. Disease severity and Dermatology Life Quality Index (DLQI) were significant predictors for dTTO across all diseases. In AA patients, female gender was a strong predictor for a dTTO of more than 30 minutes, possibly due to the impact of hair loss on women's appearance and self-esteem. Socioeconomic status was not a significant predictor, suggesting that income did not majorly impact reported dTTO. The study had limitations including potential selection bias and lack of objective measures of disease severity.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

      community mbp alopecia areata or vitamin deficiency

      in Chat 5 months ago
      A 19-year-old male has been using topical finasteride and minoxidil for 8 months with no progress and is considering seeking a second opinion due to potential misdiagnosis. The discussion revolves around whether the hair loss is due to male pattern baldness, alopecia areata, or a vitamin deficiency.

      community Olumiant alternative for Alopecia Areata?

      in Treatment  1 upvotes 1 year ago
      A user with alopecia areata is considering treatment options like injections or Olumiant but is concerned about cost and whether delaying treatment will lead to permanent hair loss. They are seeking alternative treatments that are more affordable for a college student.

    Similar Research

    6 / 1000+ results